Chris Weekes

I joined the biotechnology, chemistry and pharmaceutical team at D Young & Co in 2022. My background is primarily in molecular biology and biochemistry, with experience in immunology and immunotherapy.

Since joining the firm, I have been introduced to a range of areas of patent law, including drafting, prosecution and opposition. This has covered a diverse range of clients and fields of bioscience, and I’ve carried out work on gene editing, vaccines, immunotherapies and many more, for small start-ups through to large multinational corporations.

I completed my undergraduate studies in Natural Sciences in Cambridge, before undertaking a PhD in Biochemistry at Imperial College London. My research focused on the mechanism of DNA replication initiation, utilising engineered protein constructs in combination with mass spectrometry and genomic techniques. I also spent time in the clinical trials space prior to my PhD working on projects related to cancer immunotherapy data.